News Focus
News Focus
Followers 231
Posts 21726
Boards Moderated 1
Alias Born 08/03/2006

Re: None

Tuesday, 04/04/2017 11:55:44 AM

Tuesday, April 04, 2017 11:55:44 AM

Post# of 20617
I think we'll be seeing the FDA step up their game getting generics out of their inbox. From what I see so far for 2017, they have some catching up to do. Fluticare would be nice to see this summer. INNV should get a nice short term boost imo.


FDA subscription to receive updates if you want them, very helpful if you're playing a lot of different bio's.

https://public.govdelivery.com/accounts/USFDA/subscribers/qualify?topic_id=USFDA_9&email=&commit=Subscribe

This was sent out yesterday.
Generics...
https://www.fda.gov/Drugs/DevelopmentApprovalProcess/HowDrugsareDevelopedandApproved/DrugandBiologicApprovalReports/ANDAGenericDrugApprovals/ucm2007009.htm?source=govdelivery&utm_medium=email&utm_source=govdelivery


"Perfection is not attainable, but if we chase perfection we can catch
excellence." Vince Lombardi
Do your research! Play the TA. All posts are my opinion.

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today